Lorin Gresser

CEO at Dem Dx

Lorin Gresser is the Co-Founder and CEO of Dem Dx Limited, a prominent clinical reasoning platform designed to assist healthcare professionals in assessing and triaging patients effectively. She established the company in 2015 after completing her medical degree at King's College London. Dem Dx has gained recognition for its innovative approach to improving clinical decision-making and has received multiple awards, including the Women in Innovation Award from Innovate UK and the Seal of Excellence from the European Horizon 2020 program.1 2 4

Educational Background

MBBS: King's College London
BA (Hons): University of Cambridge (Natural Sciences)
MBA: Harvard Business School

Professional Experience

Before founding Dem Dx, Gresser held significant roles in finance and consulting:

Head of Alternative Investments at Threadneedle Investments (2006-2010)
Director of Strategy at Threadneedle Investments (2000-2006)
Consultant at Boston Consulting Group (1998-2000).2 3

Contributions and Vision

Gresser's vision for Dem Dx stems from her experiences in the healthcare sector, where she recognized the need for tools that enhance clinical reasoning capabilities among frontline healthcare workers. The platform combines artificial intelligence with clinical expertise to empower nurses, paramedics, and other professionals to make informed decisions.4 5 She emphasizes collaboration with users during product development to ensure that innovations meet real-world needs.

Recognition and Impact

Lorin Gresser has been acknowledged as a Global Scholar Speaker at the Aspen Ideas Festival and has played a crucial role in securing funding for Dem Dx through various awards aimed at promoting health innovation.1 2 4 Her leadership is characterized by a commitment to improving healthcare delivery, particularly in resource-constrained environments.